Gastos com a judicialização de medicamentos: uma revisão integrativa

The judicialization of health is a phenomenon that began in Brazil after the promulgation of the Federal  Constitution of 1988, which standardized the  guarantee of health as a social right. The number of  lawsuits that require some input or health service  from the State has been growing every year, which  directly affects health financing. For this reason, the  objective of this study was to carry out a  bibliographic survey about the expenses with the  purchase of medicines via legal demands. To this  end, an integrative review was carried out based on research in Medline, Lilacs, Scielo and Scopus  databases. Initially, 857 studies were found, with  appreciation of titles and abstracts and peer review. At the end of the search, nine articles remained that had sufficient data for the proposed study and  relationship with the inclusion criteria. The selected  texts were mostly concentrated in the South and  Southeast regions of Brazil, dealing mainly with the  requisition of medicines that act on the nervous  system, but also with antineoplastic and  immunomodulatory agents (the most expensive  ones). It was also possible to notice that there is no  standardization in the source of financial data and  that the expense with the judicialization of medicines  is high: both the municipal and state  studies, as well as the one that only analyzed data  from the Union, presented values of R$350 thousand to R$219 million reais. In addition, the low presence  of the medicines requested in court was observed in  the official lists.